Waystar: strong bookings and margins, but Q4 revenue growth set to slow
Waystar's Q3 revenue rose 21% and adjusted EBITDA 24%, and it raised full-year EBITDA guidance, according to TradingView.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Waystar's Q3 revenue rose 21% and adjusted EBITDA grew 24%. TradingView reports that the company pointed to strong bookings and cash generation.
However, revenue growth in the fourth quarter may slow. Longer implementation ramps, shifts in the mix of patient payments and the timing of Iodine contributions are weighing on the outlook. Full-year EBITDA guidance was nonetheless increased.
why it matters
For investors the picture is mixed: strong demand and margins sit alongside a more cautious view of year-end revenue. The key question is how quickly bookings turn into revenue.
market impact
WAY shares: strong results and higher EBITDA guidance offset by slower Q4 revenue growth
- WAY shares mixed — higher EBITDA guidance supports the stock, while slower Q4 revenue growth holds it back
tags
instruments
sources
- WAY: Strong bookings and margins meet longer revenue conversion timelines and softer Q4 growth — TradingView, 2 November 2026 at 23:56 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗